Before joining PhotonPharma, Derek served as the Global Commercial Development Lead at Rallybio, where he developed the ...
German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...
The U.S. stock market is off to a great start in 2024. Through Feb. 23, both the S&P 500 and the Nasdaq-100 are up more than 7% year to date (YTD). The Dow Jones Industrial Average is up nicely as ...